MKI67 and neoplasm: Moreover, treatment with dasatinib increased cellular differentiation of the primary tumor and, in line with our in vitro proliferation studies, significantly reduced Ki67 expression (two-sided Student’s t test, p < 0.01, Additional file 1: Figure S4B).